Update of acute and long-term tolvaptan therapy
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference47 articles.
1. Experience of a vasopressin receptor antagonist, tolvaptan, under the unique indication in Japanese heart failure patients;Kinugawa;Clin Pharmacol Ther,2013
2. Tolvaptan can improve clinical course in responders;Imamura;Int Heart J,2013
3. Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study);Kinugawa;Int Heart J,2015
4. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry);Sato;Circ J,2013
5. Guidelines for Diagnosis and Treatment of Acute and Chronic Heart Failure. 2018. http://www.j-circ.or.jp/guideline/pdf/JCS2017_tsutsui_h.pdf.
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Short-term impact of kampo goreisan in patients with congestive heart failure refractory to tolvaptan-incorporated medical therapy;Heart and Vessels;2024-06-21
2. Treatment strategies for diuretic resistance in patients with heart failure;Journal of Cardiology;2024-06
3. Impact of Tolvaptan Combined with Low-Dose Dopamine in Heart Failure Patients with Acute Kidney Injury;International Heart Journal;2024-05-31
4. The potential effectiveness of tolvaptan independent of cardiac disease in critically ill patients: A retrospective observational study;2023-10-23
5. The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registry;ESC Heart Failure;2023-08-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3